Clinical validation of intraoperative indcyanine-green(ICG) fluorescence imaging in hepatecomy.

Clinical validation of intraoperative indcyanine-green(ICG) fluorescence imaging in hepatecomy. - Validation of ICG fluorescence imaging in hepatecomy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021834

Enrollment

Registered

2016-04-11

Start date

2016-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver tumor

Interventions

indocyanine green

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients performed hepatectomy from April 2016 to March 2018

Exclusion criteria

Exclusion criteria: 1)patients resected other organs except for colorectum and gallbradder 2)patients who have a history risked postoperative complication 3)patients regarded as ineligible by principal investigator or researcher

Design outcomes

Primary

Measure	Time frame
visualization of boundary between liver segments and hepatic vein-congestion area	—

Secondary

Measure	Time frame
identification of liver tumor	—

Countries

Japan

Contacts

Public ContactKenichiro Araki

Gunma University Graduate School of Medicine Department of Hepatobiliary and Pancreatic Surgery

karaki@gunma-u.ac.jp027-220-8800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026